MA stargazing reveals a different story
All the Medicare Advantage trend lines seem like they are northward bound. Enrollment, the number of plans, the number of companies selling those plans — they’re all up. So Avalere Health’s report last month on the percentage of beneficiaries in highly rated plans stood out — and not in a good way.
All the Medicare Advantage trend lines seem like they are northward bound. Enrollment, the number of plans, the number of companies selling those plans — they’re all up. So Avalere Health’s report last month on the percentage of beneficiaries in highly rated plans stood out — and not in a good way.
Related: Medicare Advantage Enrollment Keeps Growing
CMS’ Star Rating program grades the quality of Medicare Advantage plans on a scale of 1 to 5 stars, with 5 being the highest quality.
Using data that the CMS made available in October, Avalere Health calculated that approximately 11.9% of the enrollees in Medicare Advantage plans that include drug coverage are in 5-star plans, which isn’t a big difference from the 11% of enrollees in 5-star plans last year.
But the consulting firm’s numbers show that the proportion of enrollees in 4.5-star plans dropped sharply, from 31.4% last year to 19.6% this year, and the proportion in 4-star plans dipped from 38.8% last year to 30.9% this year.
Private Equity in Healthcare: Colonoscopy Prices Soar While Care Remains the Same
July 11th 2025Private equity acquisitions have increased rapidly across all aspects of healthcare, with gastroenterology practices experiencing the highest share. In the U.S., approximately 13% of gastroenterologists work in practices owned by private equity groups.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
